Sigvotatug Vedotin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Sigvotatug Vedotin, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. [Phase 3]